Therefore, we comprehensively explored the impact of SIGLEC7 on the expression patterns, biological functions, and prognostic value in glioma patients using the TCGA dataset of 702 cases and the CGGA dataset of 693 cases. This evidence concerns the gene SIGLEC7 and central nervous system cancer.